The Role of Syncytiotrophoblast Microvesicles in Pregnancy Immunity
Author Information
Author(s): Jennifer Southcombe, Dionne Tannetta, Christopher Redman, Ian Sargent, Carlos Penha-Goncalves
Primary Institution: Nuffield Department of Obstetrics and Gynaecology, University of Oxford
Hypothesis
Syncytiotrophoblast microvesicles (STBM) influence maternal immune responses during pregnancy.
Conclusion
Syncytiotrophoblast microvesicles can induce pro-inflammatory cytokine production in maternal immune cells, which may contribute to the inflammatory state of normal pregnancy.
Supporting Evidence
- Syncytiotrophoblast microvesicles can bind to maternal immune cells.
- PBMC from pregnant women produce more pro-inflammatory cytokines in response to STBM than those from non-pregnant women.
- STBM can induce the release of several cytokines including TNFα and IL-6.
Takeaway
Pregnant women have special cells from the placenta that help their immune system work differently, which is important for keeping both mom and baby healthy.
Methodology
The study involved collecting blood samples from pregnant and non-pregnant women, preparing syncytiotrophoblast microvesicles, and analyzing cytokine production in response to these microvesicles.
Potential Biases
Potential bias due to the selection of participants and the methods used for STBM preparation.
Limitations
The study was limited by the small sample size and the difficulty in obtaining pure STBM preparations.
Participant Demographics
Healthy women in their third trimester of pregnancy, mean age 32 years, 70% nulliparous.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website